A mortality analysis of letermovir prophylaxis for cytomegalovirus (CMV) in CMV-seropositive recipients of allogeneic hematopoietic cell transplantation

This post hoc mortality analysis of phase 3 data suggests that letermovir prophylaxis reduced all-cause mortality versus placebo in cytomegalovirus (CMV)-seropo

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ljungman, Per (VerfasserIn) , Schmitt, Michael (VerfasserIn) , Marty, Francisco M. (VerfasserIn) , Maertens, Johan (VerfasserIn) , Chemaly, Roy F. (VerfasserIn) , Kartsonis, Nicholas A. (VerfasserIn) , Butterton, Joan R. (VerfasserIn) , Wan, Hong (VerfasserIn) , Teal, Valerie L. (VerfasserIn) , Sarratt, Kendra (VerfasserIn) , Murata, Yoshihiko (VerfasserIn) , Leavitt, Randi Y. (VerfasserIn) , Badshah, Cyrus (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2020
In: Clinical infectious diseases
Year: 2020, Jahrgang: 70, Heft: 8, Pages: 1525-1533
ISSN:1537-6591
DOI:10.1093/cid/ciz490
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/cid/ciz490
Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/cid/article/70/8/1525/5513132
Volltext
Verfasserangaben:Per Ljungman, Michael Schmitt, Francisco M. Marty, Johan Maertens, Roy F. Chemaly, Nicholas A. Kartsonis, Joan R. Butterton, Hong Wan, Valerie L. Teal, Kendra Sarratt, Yoshihiko Murata, Randi Y. Leavitt, and Cyrus Badshah

MARC

LEADER 00000caa a2200000 c 4500
001 1735467529
003 DE-627
005 20230427161425.0
007 cr uuu---uuuuu
008 201013s2020 xx |||||o 00| ||eng c
024 7 |a 10.1093/cid/ciz490  |2 doi 
035 |a (DE-627)1735467529 
035 |a (DE-599)KXP1735467529 
035 |a (OCoLC)1341371086 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Ljungman, Per  |d 1950-  |e VerfasserIn  |0 (DE-588)120777698X  |0 (DE-627)169410253X  |4 aut 
245 1 2 |a A mortality analysis of letermovir prophylaxis for cytomegalovirus (CMV) in CMV-seropositive recipients of allogeneic hematopoietic cell transplantation  |c Per Ljungman, Michael Schmitt, Francisco M. Marty, Johan Maertens, Roy F. Chemaly, Nicholas A. Kartsonis, Joan R. Butterton, Hong Wan, Valerie L. Teal, Kendra Sarratt, Yoshihiko Murata, Randi Y. Leavitt, and Cyrus Badshah 
264 1 |c 2020 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published online June 8, 2019 
500 |a Gesehen am 13.10.2020 
520 |a This post hoc mortality analysis of phase 3 data suggests that letermovir prophylaxis reduced all-cause mortality versus placebo in cytomegalovirus (CMV)-seropo 
700 1 |a Schmitt, Michael  |d 1966-  |e VerfasserIn  |0 (DE-588)133177173  |0 (DE-627)538000600  |0 (DE-576)299672921  |4 aut 
700 1 |a Marty, Francisco M.  |e VerfasserIn  |4 aut 
700 1 |a Maertens, Johan  |e VerfasserIn  |4 aut 
700 1 |a Chemaly, Roy F.  |e VerfasserIn  |4 aut 
700 1 |a Kartsonis, Nicholas A.  |e VerfasserIn  |4 aut 
700 1 |a Butterton, Joan R.  |e VerfasserIn  |4 aut 
700 1 |a Wan, Hong  |e VerfasserIn  |4 aut 
700 1 |a Teal, Valerie L.  |e VerfasserIn  |4 aut 
700 1 |a Sarratt, Kendra  |e VerfasserIn  |4 aut 
700 1 |a Murata, Yoshihiko  |e VerfasserIn  |4 aut 
700 1 |a Leavitt, Randi Y.  |e VerfasserIn  |4 aut 
700 1 |a Badshah, Cyrus  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Clinical infectious diseases  |d Oxford : Oxford Journals, 1992  |g 70(2020), 8, Seite 1525-1533  |h Online-Ressource  |w (DE-627)320418308  |w (DE-600)2002229-3  |w (DE-576)090881834  |x 1537-6591  |7 nnas  |a A mortality analysis of letermovir prophylaxis for cytomegalovirus (CMV) in CMV-seropositive recipients of allogeneic hematopoietic cell transplantation 
773 1 8 |g volume:70  |g year:2020  |g number:8  |g pages:1525-1533  |g extent:9  |a A mortality analysis of letermovir prophylaxis for cytomegalovirus (CMV) in CMV-seropositive recipients of allogeneic hematopoietic cell transplantation 
856 4 0 |u https://doi.org/10.1093/cid/ciz490  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://academic.oup.com/cid/article/70/8/1525/5513132  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20201013 
993 |a Article 
994 |a 2020 
998 |g 133177173  |a Schmitt, Michael  |m 133177173:Schmitt, Michael  |d 910000  |d 910100  |e 910000PS133177173  |e 910100PS133177173  |k 0/910000/  |k 1/910000/910100/  |p 2 
999 |a KXP-PPN1735467529  |e 3779726246 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1735467529","name":{"displayForm":["Per Ljungman, Michael Schmitt, Francisco M. Marty, Johan Maertens, Roy F. Chemaly, Nicholas A. Kartsonis, Joan R. Butterton, Hong Wan, Valerie L. Teal, Kendra Sarratt, Yoshihiko Murata, Randi Y. Leavitt, and Cyrus Badshah"]},"origin":[{"dateIssuedKey":"2020","dateIssuedDisp":"2020"}],"language":["eng"],"physDesc":[{"extent":"9 S."}],"id":{"doi":["10.1093/cid/ciz490"],"eki":["1735467529"]},"relHost":[{"language":["eng"],"disp":"A mortality analysis of letermovir prophylaxis for cytomegalovirus (CMV) in CMV-seropositive recipients of allogeneic hematopoietic cell transplantationClinical infectious diseases","id":{"issn":["1537-6591"],"zdb":["2002229-3"],"eki":["320418308"]},"physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"320418308","pubHistory":["14.1992 -"],"part":{"text":"70(2020), 8, Seite 1525-1533","issue":"8","pages":"1525-1533","year":"2020","volume":"70","extent":"9"},"origin":[{"publisher":"Oxford Journals ; Univ. of Chicago Press, Journals Division","dateIssuedKey":"1992","dateIssuedDisp":"1992-","publisherPlace":"Oxford ; Chicago, Ill."}],"title":[{"title":"Clinical infectious diseases","title_sort":"Clinical infectious diseases","subtitle":"electronic edition"}],"note":["Gesehen am 31.07.2023"]}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"display":"Ljungman, Per","family":"Ljungman","given":"Per","role":"aut","roleDisplay":"VerfasserIn"},{"given":"Michael","role":"aut","roleDisplay":"VerfasserIn","display":"Schmitt, Michael","family":"Schmitt"},{"family":"Marty","display":"Marty, Francisco M.","role":"aut","roleDisplay":"VerfasserIn","given":"Francisco M."},{"roleDisplay":"VerfasserIn","role":"aut","given":"Johan","family":"Maertens","display":"Maertens, Johan"},{"display":"Chemaly, Roy F.","family":"Chemaly","given":"Roy F.","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Nicholas A.","family":"Kartsonis","display":"Kartsonis, Nicholas A."},{"roleDisplay":"VerfasserIn","role":"aut","given":"Joan R.","family":"Butterton","display":"Butterton, Joan R."},{"family":"Wan","display":"Wan, Hong","role":"aut","roleDisplay":"VerfasserIn","given":"Hong"},{"family":"Teal","display":"Teal, Valerie L.","role":"aut","roleDisplay":"VerfasserIn","given":"Valerie L."},{"family":"Sarratt","display":"Sarratt, Kendra","role":"aut","roleDisplay":"VerfasserIn","given":"Kendra"},{"given":"Yoshihiko","roleDisplay":"VerfasserIn","role":"aut","display":"Murata, Yoshihiko","family":"Murata"},{"family":"Leavitt","display":"Leavitt, Randi Y.","role":"aut","roleDisplay":"VerfasserIn","given":"Randi Y."},{"given":"Cyrus","roleDisplay":"VerfasserIn","role":"aut","display":"Badshah, Cyrus","family":"Badshah"}],"title":[{"title":"A mortality analysis of letermovir prophylaxis for cytomegalovirus (CMV) in CMV-seropositive recipients of allogeneic hematopoietic cell transplantation","title_sort":"mortality analysis of letermovir prophylaxis for cytomegalovirus (CMV) in CMV-seropositive recipients of allogeneic hematopoietic cell transplantation"}],"note":["Published online June 8, 2019","Gesehen am 13.10.2020"]} 
SRT |a LJUNGMANPEMORTALITYA2020